SXR1096
/ Sixera
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 17, 2025
A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
(clinicaltrials.gov)
- P1/2 | N=9 | Completed | Sponsor: Sixera Pharma | Recruiting ➔ Completed | N=20 ➔ 9 | Trial completion date: Dec 2022 ➔ Aug 2025 | Trial primary completion date: Aug 2022 ➔ Jun 2025
Enrollment change • First-in-human • Trial completion • Trial completion date • Trial primary completion date
1 to 1
Of
1
Go to page
1